282 related articles for article (PubMed ID: 230108)
1. Antibody to poliovirus in older children and young adults in Israel and the use of poliovaccines for the immunization of the seronegatives.
Goldblum N; Kra-Oz Z; Swartz T
Dev Biol Stand; 1979; 43():173-7. PubMed ID: 230108
[TBL] [Abstract][Full Text] [Related]
2. Poliomyelitis vaccines in Belgium: 20 years of experience.
Andre FE
Dev Biol Stand; 1979; 43():187-93. PubMed ID: 230109
[No Abstract] [Full Text] [Related]
3. [Vaccination against poliomyelitis. Formation of immunity evaluated according to the results of serological surveys].
Zabicka J
Przegl Epidemiol; 1981; 35(3):385-9. PubMed ID: 6276928
[No Abstract] [Full Text] [Related]
4. [Poliomyelitis vaccination in Denmark].
Petersen I
Ugeskr Laeger; 1985 Jan; 147(4):265-9. PubMed ID: 3976028
[No Abstract] [Full Text] [Related]
5. The problems of poliovirus immunization.
Fulginiti VA
Hosp Pract; 1980 Aug; 15(8):61-7. PubMed ID: 6249713
[No Abstract] [Full Text] [Related]
6. Antipolio prophylaxis of immunocompromised children during a nationwide oral poliovaccine campaign.
Stenvik M; Hovi L; Siimes MA; Roivainen M; Hovi T
Pediatr Infect Dis J; 1987 Dec; 6(12):1106-10. PubMed ID: 2829105
[TBL] [Abstract][Full Text] [Related]
7. Criteria for control of infectious diseases with poliomyelitis as an example.
Evans AS
Prog Med Virol; 1984; 29():141-65. PubMed ID: 6322231
[No Abstract] [Full Text] [Related]
8. Intestinal immunity following a combined enhanced inactivated polio vaccine/oral polio vaccine programme in Israel.
Swartz TA; Green MS; Handscher R; Sofer D; Cohen-Dar M; Shohat T; Habib S; Barak E; Dror Z; Somekh E; Peled-Leviathan T; Yulzari R; Libling A; Mendelson E; Shulman LM
Vaccine; 2008 Feb; 26(8):1083-90. PubMed ID: 18241962
[TBL] [Abstract][Full Text] [Related]
9. Oral poliovaccine: will it help eradicate polio or cause the next epidemic?
Shulman LM; Manor Y; Sofer D; Swartz T; Mendelson E
Isr Med Assoc J; 2006 May; 8(5):312-5. PubMed ID: 16805227
[TBL] [Abstract][Full Text] [Related]
10. Antibody status to poliomyelitis, measles, rubella, diphtheria and tetanus, Ontario, 1969-70: deficiencies discovered and remedies required.
MacLeod DR; Ing WK; Belcourt RJ; Pearson EW; Bell JS
Can Med Assoc J; 1975 Oct; 113(7):619-23. PubMed ID: 1181016
[TBL] [Abstract][Full Text] [Related]
11. Benefits and risks of attenuated polio vaccine strains in a community immunized with inactivated polio vaccine.
Rossier E; Phipps PH; Pépin O
Dev Biol Stand; 1979; 43():179-85. PubMed ID: 520669
[No Abstract] [Full Text] [Related]
12. [Worldwide eradication of poliomyelitis].
Rasch G; Schreier E; Kiehl W; Kurth R
Wien Klin Wochenschr; 2001 Oct; 113(20-21):839-45. PubMed ID: 11732120
[TBL] [Abstract][Full Text] [Related]
13. [Findings on the success of vaccination and revaccination with live and inactivated vaccines against poliomyelitis].
Dostal V; Haenzel I; Sturm W
Schweiz Med Wochenschr; 1969 Sep; 99(37):1322-4. PubMed ID: 4309326
[No Abstract] [Full Text] [Related]
14. Poliovirus antibodies in age groups: an assessment of obligatory vaccination in Belgium.
Lamy ME; Cornu C; Desmyter J
Dev Biol Stand; 1979; 43():207-13. PubMed ID: 230111
[TBL] [Abstract][Full Text] [Related]
15. The natural history of poliomyelitis in Israel, 1949-1982.
Goldblum N; Swartz T; Gerichter CB; Handsher R; Lasch EE; Melnick JL
Prog Med Virol; 1984; 29():115-23. PubMed ID: 6366916
[No Abstract] [Full Text] [Related]
16. [A comparison of the effectiveness of mass immunization campaign of trivalent oral poliovirus vaccine (TOPV) by epidemiological serosurvey. Shandong Collaborating Group for Poliomyelitis Control and Surveillance, Jinan, Shandong].
Xu A
Zhonghua Liu Xing Bing Xue Za Zhi; 1992 Oct; 13(5):261-4. PubMed ID: 1338626
[TBL] [Abstract][Full Text] [Related]
17. Immunogenicity of oral poliovirus vaccine administered in mass campaigns versus routine immunization programmes.
Richardson G; Linkins RW; Eames MA; Wood DJ; Campbell PJ; Ankers E; Deniel M; Kabbaj A; Magrath DI; Minor PD
Bull World Health Organ; 1995; 73(6):769-77. PubMed ID: 8907770
[TBL] [Abstract][Full Text] [Related]
18. Poliomyelitis vaccination. Evaluation and direction in continuing application.
Sabin AB
Am J Clin Pathol; 1978 Jul; 70(1 Suppl):136-40. PubMed ID: 210653
[No Abstract] [Full Text] [Related]
19. [Revaccination by oral monovalent poliovaccine type 3 (author's transl)].
Srámová H; Teplý V; Bernatziková V
Cesk Epidemiol Mikrobiol Imunol; 1981 Mar; 30(2):95-100. PubMed ID: 6261973
[No Abstract] [Full Text] [Related]
20. Poliomyelitis outbreak in Israel in 1988: a report with two commentaries.
Slater PE; Orenstein WA; Morag A; Avni A; Handsher R; Green MS; Costin C; Yarrow A; Rishpon S; Havkin O
Lancet; 1990 May; 335(8699):1192-5; discussion 1196-8. PubMed ID: 1971043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
